Flow diversion is a novel therapeutic approach for the treatment of anatomically challenging intracranial aneurysms, and this approach has gained traction over the years. Flow diversion aneurysm is an endovascular technique in which the device is placed in the parent blood vessel to divert blood flow away from the aneurysm itself. The technological advancements along with the clinical results indicate that flow diversion aneurysm is safe as well as effective in the treatment of ruptured aneurysms, posterior circulation aneurysms, and distal anterior circulation aneurysms.
Increase in incidence of brain aneurysm and rise in demand for minimally invasive endovascular surgeries drive the market. However, risk of post-operative complications and stringent regulations regarding the approval of the devices restrain the market growth. Moreover, technological advancements in the flow diversion aneurysm treatment offer lucrative opportunities for the expansion of the market.
The market is segmented on the basis of region. Based on region, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key players that operate in the market are Balt Extrusion, Medtronic Plc, Stryker Corporation, Acandis GmbH, InspireMD, phenox GmbH, and MicroVention, Inc.
Key Benefits
- The study provides an in-depth analysis of the global flow diversion aneurysm market with current trends and future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis to enable stakeholders to capitalize on prevailing market opportunities.
- Key players are profiled and their strategies thoroughly analyzed, which predicts the competitive outlook of the market.
Flow Diversion Aneurysm Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Region |
|
 Key Market Players | Stryker Corporation, Cardinal Health Inc., MicroVention, Inc., Medtronic Plc, Cook Group Inc., InspireMD, Phenox GmbH, Acandis GmbH, Boston Scientific Corp., Balt Extrusion |
Loading Table Of Content...
